Ticker: GL

Globe Life

Finance Financials Insurance - Life

Price 173.48

Reco Buy Potential 69 Risk 36 Updated 2026-07-27

Official website

Forecast impact

positive

Target +15.3% target fill 86.7%

Reaction D5 +4.62% · D10 pending fresh confirmed · market trust

Impact Potential +6 · Risk -3 valid until 2026-08-14

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

Globe Life Inc. is a financial services company primarily engaged in providing life insurance and supplemental health insurance products. Its core offerings include individual life insurance, annuities, and various health-related insurance policies. The company operates through multiple segments, focusing on life insurance, health insurance, and annuity products, generating revenue mainly from premiums and investment income.

Investment Profile

The investment profile of Globe Life is more aligned with value investors, given its stable revenue growth and modest dividend yield. The company demonstrates consistent performance with a focus on long-term financial stability, making it suitable for those seeking a balanced approach to investment.

Category: Finance Sector: Financials Industry: Insurance - Life Investment style: Balanced Horizon: Medium-term Company type: Blue Chip Company type: Large Cap Experience: Basic

Fundamental metrics (experimental) Updated: 2026-07-27

EPS (TTM) — earnings per share for the last 12 months, $: 14.70
Revenue QoQ — quarter-over-quarter revenue growth: 2.3%
EPS surprise: -0.9%
20d volatility: 1.7%
Dividend yield: 0.9%
last ex-date: 2026-07-06

AI recommendation changes

Date	Before	After	Reason
2026-07-26	Hold	Buy	Mixed performance; cautious outlook amid market volatility.
2026-07-24	Buy	Hold	Negative momentum and high risk outweigh potential upside.
2026-06-09	Hold	Buy	Moderate growth; recent EPS surprise raises concerns.
2026-06-01	Buy	Hold	Stable fundamentals but mixed momentum signals.
2026-05-22	Sell	Buy	Moderate growth with stable fundamentals; cautious outlook.
2026-05-20	Buy	Sell	Weak momentum and high risk limit upside potential.
2026-05-08	—	Buy	Mixed performance; cautious outlook on fundamentals.
2026-05-08	Buy	Buy	Компания показывает стабильный рост выручки и положительную динамику на длительном горизонте, однако недавние колебания цен и небольшой сюрприз по прибыли могут указывать на краткосрочные риски.
2026-04-01	Hold	Buy	Компания демонстрирует стабильный рост и умеренный дивидендный доход, однако недавние колебания цен и отрицательный сюрприз по прибыли могут указывать на необходимость осторожности.
2026-03-06	Buy	Hold	Компания показывает умеренный рост за последние 60 дней, однако недавние колебания цен и низкий дивидендный доход могут указывать на неопределенность. Рекомендуется удерживать акции до получения более ясных сигналов о тр
2026-02-02	Hold	Buy	Компания демонстрирует стабильный рост за последние 60 дней, однако отсутствие данных по EPS и доходам вызывает осторожность. Рекомендуется удерживать акции до получения более ясной финансовой информации.

Analyst forecasts

Date	Analyst	Action	Target	Price Then
2026-07-15	Piper Sandler	Target Raised	175 → 200	178.99
2026-07-10	Jefferies	Target Raised	147 → 166	178.86
2026-05-26	Piper Sandler	Target Raised	167 → 175	156.28
2026-05-21	Morgan Stanley	Target Raised	176 → 181	155.3
2026-04-24	Truist Financial	Target Raised	180 → 185	153.55
2026-02-18	Evercore ISI	Target Raised	155 → 157	144.86
2025-12-15	Morgan Stanley	Target Lowered	177 → 176	140.82
2025-11-21	Piper Sandler	Update	— → 167	133.61
2025-10-24	Truist Financial	Target Raised	150 → 158	134.49
2025-10-07	Morgan Stanley	Target Raised	171 → 179	134.91
2025-08-05	Morgan Stanley	Rating Upgraded	— → 166	139.51

News Page 1 of 1

Nothing yet